Effectiveness of Probiotics in Relieving Allergic Rhinitis in Children

NCT06676111 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-10-06

No results posted yet for this study

Summary

To evaluate the clinical efficacy of probiotic gummies in the trial of allergic rhinitis in children compared to placebo, as well as the modulating effect on gut microbiota, serum metabolic profile, and occurrence of adverse reactions.

Conditions

  • Children With Allergic Rhinitis

Interventions

DIETARY_SUPPLEMENT

Probiotic

The experimental phase of this study lasts 56 days and each patient will have 3 visits (W0, W4, W8)

DIETARY_SUPPLEMENT

Placebo

The experimental phase of this study lasts 56 days and each patient will have 3 visits (W0, W4, W8)

Sponsors & Collaborators

  • Wecare Probiotics Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-10
Primary Completion
2025-02-10
Completion
2025-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06676111 on ClinicalTrials.gov